| Literature DB >> 28066251 |
Ekaterina Proshkina1, Ekaterina Lashmanova2, Eugenia Dobrovolskaya1, Nadezhda Zemskaya3, Anna Kudryavtseva4, Mikhail Shaposhnikov3, Alexey Moskalev5.
Abstract
The modulation of longevity genes and aging-associated signaling pathways using pharmacological agents is one of the potential ways to prolong the lifespan and increase the vitality of an organism. Phytochemicals flavonoids and non-steroidal anti-inflammatory drugs have a large potential as geroprotectors. The goal of the present study was to investigate the effects of long-term and short-term consumption of quercetin, (-)-epicatechin, and ibuprofen on the lifespan, resistance to stress factors (paraquat, hyperthermia, γ-radiation, and starvation), as well as age-dependent physiological parameters (locomotor activity and fecundity) of Drosophila melanogaster. The long-term treatment with quercetin and (-)-epicatechin didn't change or decreased the lifespan of males and females. In contrast, the short-term treatment with flavonoids had a beneficial effect and stimulated the resistance to paraquat and acute γ-irradiation. The short-term ibuprofen consumption had a positive effect on the lifespan of females when it was carried out at the middle age (30-40 days), and to the survival of flies under conditions of oxidative and genotoxic stresses. However, it didn't change the lifespan of males and females after the treatment during first 10 days of an imago life. Additionally, quercetin, (-)-epicatechin, and ibuprofen decreased the spontaneous locomotor activity of males, but had no effect of stimulated the physical activity and fecundity of females. Revealed quercetin, (-)-epicatechin, and ibuprofen activity can be associated with the stimulation of stress response mechanisms through the activation of pro-longevity pathways, or the induction of hormesis.Entities:
Keywords: (-)-epicatechin; Caenorhabditis elegans; Drosophila melanogaster; ibuprofen; lifespan; quercetin; stress resistance
Year: 2016 PMID: 28066251 PMCID: PMC5179547 DOI: 10.3389/fphar.2016.00505
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Primers for real-time RT-PCR.
| 5′-GCAACTCCACTGCCATCC-3′ | 5′-CCTGCTCCTCCTCGAACT-3′ | |
| 5′-TGCACGAGTTCGGTGACAACAC-3′ | 5′-TCCTTGCCATACGGATTGAAGTGC-3′ | |
| 5′-GCAAACGCACAACCAAAC-3′ | 5′-GGCCATCAGGCAGAAGAG-3′ | |
| 5′-AGAAGACGGTGCATTTGAGATTGC-3′ | 5′-CCTCGCAAACAATGAAGCCATCG-3′ | |
| 5′-AGATTGCTGCAGATGAGCAAAGCC-3′ | 5′-TTTATAACGCACGCCAGGAGAGGT-3′ | |
| 5′-TCCTCAGCGGAGACCAGA-3′ | 5′-CACGTTCGCCCTCATACA-3′ |
Lifespan parameters of .
| Control (1) | 2 | 40.5 ± 1.3 | 47 | 58 | 76 | 9.6 | 0.076 | 0.0024 | 153 | |
| Quercetin (1) | 0.3 μM | 2 | 40.1 ± 1.5 | 47 | 49 | 55 | 5.6 | 0.123 | 0.0004 | 92 |
| 0.5 μM | 2 | 32.4 ± 1.7 | 41 | 48 | 55 | 10.7 | 0.065 | 0.0055 | 97 | |
| 1.0 μM | 2 | 41.7 ± 1.3 | 47 | 49 | 63 | 6.1 | 0.114 | 0.0006 | 92 | |
| (-)-Epicatechin (1) | 0.3 μM | 2 | 43.8 ± 1.0 | 48 | 55 | 72 | 7.0 | 0.099 | 0.0008 | 144 |
| 0.5 μM | 6 | 44.7 ± 1.4 | 47 | 66 | 68 | 9.5 | 0.073 | 0.0017 | 127 | |
| 1.0 μM | 2 | 37.9 ± 1.3 | 42 | 55 | 62 | 8.7 | 0.079 | 0.0024 | 150 | |
| Control (2) | 2 | 48.7 ± 1.3 | 48 | 72 | 82 | 11.4 | 0.061 | 0.0020 | 193 | |
| Quercetin (2) | 0.3 μM | 5 | 46.6 ± 1.0 | 48 | 64 | 78 | 9.8 | 0.071 | 0.0016 | 212 |
| 0.5 μM | 13 | 46.1 ± 1.1 | 42 | 64 | 79 | 11.2 | 0.062 | 0.0024 | 193 | |
| 1.0 μM | 2 | 35.2 ± 1.0 | 28 | 62 | 78 | 14.6 | 0.048 | 0.0077 | 208 | |
| (-)-Epicatechin (2) | 0.3 μM | 2 | 37.3 ± 1.0 | 35 | 62 | 64 | 11.0 | 0.063 | 0.0043 | 196 |
| 0.5 μM | 2 | 50.7 ± 1.1 | 50 | 68 | 78 | 9.3 | 0.074 | 0.0010 | 191 | |
| 1.0 μM | 2 | 41.1 ± 1.5 | 28 | 72 | 93 | 19.4 | 0.036 | 0.0074 | 183 | |
| Control (1) | 2 | 46.9 ± 1.3 | 48 | 62 | 82 | 9.0 | 0.078 | 0.0013 | 134 | |
| Quercetin (1) | 0.3 μM | 2 | 41.3 ± 1.6 | 47 | 55 | 65 | 7.9 | 0.088 | 0.0014 | 86 |
| 0.5 μM | 2 | 44.4 ± 1.5 | 48 | 61 | 68 | 7.6 | 0.091 | 0.0009 | 86 | |
| 1.0 μM | 2 | 35.9 ± 1.7 | 40 | 55 | 62 | 10.9 | 0.064 | 0.0045 | 90 | |
| (-)-Epicatechin (1) | 0.3 μM | 2 | 43.4 ± 1.5 | 49 | 62 | 79 | 10.4 | 0.067 | 0.0023 | 131 |
| 0.5 μM | 5 | 41.1 ± 0.8 | 38 | 59 | 76 | 9.7 | 0.071 | 0.0026 | 219 | |
| 1.0 μM | 2 | 42.0 ± 1.4 | 47 | 56 | 93 | 11.3 | 0.061 | 0.0033 | 129 | |
| Control (2) | 2 | 56.4 ± 1.0 | 58 | 72 | 78 | 7.3 | 0.096 | 0.0003 | 180 | |
| Quercetin (2) | 0.3 μM | 2 | 55.9 ± 1.0 | 57 | 68 | 78 | 6.9 | 0.100 | 0.0002 | 190 |
| 0.5 μM | 7 | 54.2 ± 0.9 | 56 | 64 | 78 | 7.0 | 0.099 | 0.0003 | 194 | |
| 1.0 μM | 2 | 56.8 ± 0.9 | 57 | 68 | 79 | 5.9 | 0.118 | 0.0001 | 188 | |
| (-)-Epicatechin (2) | 0.3 μM | 2 | 52.3 ± 1.0 | 54 | 65 | 97 | 9.2 | 0.075 | 0.0009 | 199 |
| 0.5 μM | 2 | 61.8 ± 1.0 | 64 | 78 | 96 | 8.2 | 0.084 | 0.0003 | 206 | |
| 1.0 μM | 2 | 57.4 ± 1.1 | 62 | 72 | 89 | 8.1 | 0.086 | 0.0004 | 166 | |
Min, minimum lifespan, days; , mean lifespan and standard error of mean, days; M, median lifespan, days; 90%, age of 90% mortality, days; Max, maximum lifespan, days; MRTD, mortality rate time of doubling; α and R0, Gompertz equation parameters; N, number of flies in a sample; (1), (2), replications;
p < 0.05,
p < 0.001, data in forth column calculated by Cox–Mantel test, in fifth column calculated by Gehan-Breslow-Wilcoxon test, in sixth column calculated by Wang–Allison method.
Figure 1Survivorship curves of and (-)-epicatechin (B) during lifetime (combined data of two independent replications); *p < 0.05, **p < 0.001, Kolmogorov-Smirnov test.
Figure 2Survivorship curves of and at the age of 30–40 days (B); *p < 0.05, **p < 0.001, Kolmogorov-Smirnov test.
Figure 3Fecundity of , (-)-epicatechin (B), and ibuprofen (C), *p < 0.001, χ2-test.
Figure 4Spontaneous locomotor activity of , (-)-epicatechin (B), and ibuprofen (C); *p < 0.001, χ2-test.
Survival parameters of .
| Control | 37.6 ± 1.3 | 28 | 54 | 118 | 23.8 ± 1.2 | 15 | 40 | 113 | |
| Quercetin | 0.3 μM | 41.3 ± 1.3 | 40 | 54 | 118 | 23.3 ± 1.0 | 15 | 40 | 120 |
| 0.5 μM | 42.7 ± 1.4 | 40 | 54 | 116 | 24.1 ± 1.0 | 28 | 40 | 116 | |
| 1.0 μM | 40.9 ± 1.6 | 40 | 54 | 110 | 31.2 ± 2.1 | 15 | 89 | 136 | |
| (-)-Epicatechin | 0.3 μM | 38.1 ± 1.4 | 40 | 54 | 111 | 24.9 ± 1.2 | 15 | 52 | 123 |
| 0.5 μM | 43.2 ± 1.6 | 40 | 64 | 119 | 34.6 ± 2.0 | 28 | 64 | 118 | |
| 1.0 μM | 48.5 ± 1.9 | 47 | 76 | 110 | 32.2 ± 1.6 | 28 | 64 | 125 | |
| Ibuprofen | 0.3 μM | 44.6 ± 1.9 | 40 | 64 | 107 | 26.7 ± 1.5 | 28 | 54 | 117 |
| 0.5 μM | 43.6 ± 1.6 | 40 | 64 | 109 | 36.1 ± 1.7 | 28 | 64 | 127 | |
| 1.0 μM | 48.6 ± 1.5 | 54 | 64 | 126 | 41.8 ± 2.4 | 28 | 89 | 119 | |
| Control | 68.3 ± 1.9 | 66 | 90 | 133 | 63.5 ± 1.0 | 66 | 74 | 133 | |
| Quercetin | 0.3 μM | 70.9 ± 1.5 | 66 | 90 | 136 | 58.0 ± 0.9 | 66 | 66 | 132 |
| 0.5 μM | 63.6 ± 1.4 | 66 | 90 | 136 | 68.0 ± 1.0 | 66 | 90 | 130 | |
| 1.0 μM | 67.9 ± 1.4 | 66 | 90 | 150 | 55.9 ± 0.9 | 66 | 66 | 146 | |
| (-)-Epicatechin | 0.3 μM | 57.6 ± 1.3 | 66 | 74 | 152 | 66.6 ± 0.7 | 66 | 74 | 141 |
| 0.5 μM | 69.9 ± 1.5 | 66 | 90 | 135 | 57.1 ± 1.0 | 66 | 66 | 119 | |
| 1.0 μM | 62.4 ± 1.2 | 66 | 74 | 152 | 64.2 ± 1.1 | 66 | 66 | 75 | |
| Ibuprofen | 0.3 μM | 60.9 ± 1.5 | 66 | 90 | 163 | 52.9 ± 1.2 | 49 | 66 | 138 |
| 0.5 μM | 52.0 ± 1.2 | 45.5 | 66 | 154 | 59.3 ± 0.9 | 66 | 66 | 145 | |
| 1.0 μM | 50.3 ± 1.2 | 49 | 66 | 143 | 55.2 ± 1.2 | 66 | 66 | 111 | |
| Control | 31.6 ± 0.9 | 32 | 44 | 147 | 49.8 ± 0.8 | 44 | 56 | 134 | |
| Quercetin | 0.3 μM | 29.2 ± 0.6 | 32 | 32 | 151 | 47.6 ± 0.8 | 44 | 56 | 157 |
| 0.5 μM | 31.1 ± 0.5 | 32 | 32 | 147 | 51.0 ± 0.9 | 56 | 69 | 148 | |
| 1.0 μM | 30.7 ± 0.6 | 32 | 32 | 149 | 45.9 ± 1.0 | 44 | 68 | 142 | |
| (-)-Epicatechin | 0.3 μM | 29.6 ± 0.6 | 32 | 32 | 124 | 45.5 ± 0.8 | 44 | 56 | 153 |
| 0.5 μM | 29.7 ± 0.5 | 32 | 32 | 155 | 41.6 ± 0.9 | 44 | 56 | 149 | |
| 1.0 μM | 32.8 ± 0.4 | 32 | 32 | 145 | 49.9 ± 0.9 | 44 | 69 | 140 | |
| Ibuprofen | 0.3 μM | 31.8 ± 0.4 | 32 | 32 | 152 | 47.5 ± 0.9 | 44 | 56 | 150 |
| 0.5 μM | 31.1 ± 0.5 | 32 | 32 | 149 | 50.9 ± 0.9 | 56 | 69 | 151 | |
| 1.0 μM | 32.5 ± 0.5 | 32 | 32 | 143 | 49.2 ± 1.1 | 44 | 56 | 122 | |
, mean survival and standard error of mean, h; M, median survival, h; 90%, age of 90% mortality, h; N, number of flies in a sample;
p < 0.05,
p < 0.001, data in third and seventh columns calculated by Cox–Mantel test, in fourth and eighth columns calculated by Gehan-Breslow-Wilcoxon test, in fifth and ninth columns calculated by Wang–Allison method.
Figure 5Resistance to oxidative stress (20 mM paraquat) (A), heat shock (35°C) (B) and starvation (C) of Drosophila melanogaster males (♂♂) and females (♀♀) treated with quercetin, (-)-epicatechin, and ibuprofen; *p < 0.05, **p < 0.001, Kolmogorov-Smirnov test.
Figure 6Resistance to acute γ-irradiation (1000 Gy) of .
Figure 7Expression of stress-response genes in .
Figure 8Positive and negative effects of quercetine.
Figure 9Positive and negative effects of (-)-epicatechin.
Figure 10Positive and negative effects of ibuprofen.